Business Wire

BELFOR, the Global Market Leader in Damage Restoration, Expands its Geographical Coverage With SSG Group, Scandinavia

22.6.2022 17:59:00 EEST | Business Wire | Press release

Share

BELFOR, the world’s leading provider of disaster recovery services, and SSG, the Scandinavian market leader in damage restoration services, have joined forces to strengthen their customer service in Denmark, Sweden and Norway.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220622005595/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

BELFOR, the Global Market Leader in Damage Restoration, Expands its Geographical Coverage With SSG Group, Scandinavia (Graphic: Business Wire)

BELFOR, now with more than 12.500 employees in 500+ locations throughout the world, covers the whole value chain in disaster recovery - from damage assessment, first mitigation measures, restoration to reconstruction services for small, large and technically complex losses.

SSG Group provides a broad service offering focussing on damage prevention, damage restoration, repair and reconstruction services with 980 employees in 57 locations in Denmark, Sweden and Norway.

“With SSG, we will grow our skilled and experienced teams with great people, increase our service capability and optimize our response times for our national and international clients”, explains Elvir Kolak, CEO of BELFOR Europe.

Carsten Fensholt, CEO of SSG Group, adds: "This transaction means a tremendous boost for our organizations in Denmark, Norway and Sweden as it adds the technical competence of BELFOR to our service portfolio and provides new development opportunities for our employees.”

BELFOR will now be the number 1 restoration company in Denmark supported by 650 people. This acquisition represents a significant step forward in terms of BELFOR’s geographical expansion into Scandinavia, which has started in Denmark in 2016 with the acquisition of Rosva followed by Rolund in 2021.

"We are happy to welcome SSG to our BELFOR family and are excited to support their future growth. SSG employs wonderful people with a great customer focus - a perfect match! We are proud to have them on board. Our growth plans are ambitious and we are looking for more great companies to join the BELFOR family - in Scandinavia as well as across Europe”, concludes Sheldon Yellen, the global CEO of BELFOR.

ABOUT BELFOR

BELFOR is the world's leading provider of disaster recovery services. BELFOR has over 40 years of experience, covering the whole value chain from damage assessment, restoration and renovation services. This makes us a preferred partner for the insurance industry as well as for commercial and private clients.

With SSG, BELFOR will have more than 12,500 employees and 500+ locations in 57 countries. Ready to help customers on small, large and technically complex losses 24/7, 365 days a year.

www.belfor.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Cornelia Meyer von Bremen
Tel: +49 (0) 203 - 7 56 40-300
cornelia.meyervonbremen@belfor.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

From AI to Autonomous Networks: Mobileum Spark Highlights the Next Frontier of Telecom Intelligence15.10.2026 10:00:00 EEST | Press release

Mobileum Inc. ("Mobileum"), a leading global provider of telecom analytics and network solutions, brought together telecom operators and industry leaders during its Mobileum Spark events series in Lisbon (Portugal) and Frankfurt (Germany), to explore how Artificial Intelligence (AI), Agentic AI and automation are transforming network operations and accelerating the evolution toward autonomous networks. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261015172815/en/ Telecom operators, industry leaders, and Mobileum experts at Mobileum Spark 2026. Focused on Risk Management & Fraud Prevention and Network Testing & Assurance, the events featured customer-led discussions, expert insights, and real-world use cases demonstrating how AI and advanced automation are helping operators address increasing network complexity, strengthen fraud prevention, improve service assurance, and drive operational efficiency. A central theme across

Merz Therapeutics Announces Completion of Recruitment in Two Phase III Trials Investigating XEOMIN ® (incobotulinumtoxinA) for Migraine Prevention15.10.2026 09:00:00 EEST | Press release

Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, today announced the completion of patient recruitment in two global Phase III clinical trials, MINT-E (NCT07018700) and MINT-C (NCT07018713), evaluating the efficacy and safety of XEOMIN® (incobotulinumtoxinA) for the prevention of episodic and chronic migraine in adults. The trials recruited approximately 1800 adults across 109 study sites in North America and Europe. Migraine affects around 1.1 billion people worldwide, posing a significant burden on patients, society and healthcare systems.1 Both trials are evaluating the change in monthly migraine days from baseline to Month 6 as the primary endpoint. Secondary endpoints include changes in monthly headache days, acute medication days and migraine frequency during two-week periods at the end of each injection cycle. “Achieving patient recruitment for both MINT-C and MINT-E six months ahead of plan is an important milestone for our XEOMIN® migraine preven

Tourism Malaysia and Alipay+ Partner to Accelerate Malaysia’s Digital Tourism Transformation15.10.2026 08:10:00 EEST | Press release

Tourism Malaysia and Alipay+, the unified wallet gateway of Ant International, today signed a Memorandum of Understanding (MoU) to accelerate cross-border commerce and digitalise merchant engagement across Malaysia's tourism economy. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014035900/en/ (From left) Mr Mohd Akbal Setia (Head of VM2026 Secretariat and Senior Director, Advertising & Digital Tourism); Mr Mohd Amirul Rizal Abdul Rahim (Director General, Tourism Malaysia); Mr Danny Chung (General Manager of Alipay+ Global Growth Center and Vice President of Ant International); Mr Michael Guo, Alipay+ General Manager of SEA, South Asia and ANZ, Ant International) As Malaysia welcomes visitors for Visit Malaysia 2026–2027 (VM2026–2027), this partnership merges Tourism Malaysia’s destination marketing with Alipay+’s global wallet ecosystem and AI capabilities. It aims to create a highly intelligent digital journey, connecti

PeDRA 2026: Nemolizumab Phase II Data Show Long-Term Symptom Relief for Children Aged 2 to 11 Years With Moderate-to-Severe Atopic Dermatitis15.10.2026 08:00:00 EEST | Press release

Galderma (SIX: GALD), the pure-play dermatology category leader, today announced new phase II data showing that nemolizumab provided meaningful improvements in itch, sleep disturbance, and quality of life in children aged 2 to 11 years with moderate-to-severe atopic dermatitis, sustained through Week 52.1 The results will be presented at The Pediatric Dermatology Research Alliance (PeDRA) Annual Conference. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261014705800/en/ Up to 25% of children are affected by atopic dermatitis - the most common inflammatory skin disorder in this population - and around one-third of these children have moderate-to-severe disease.11,12 Atopic dermatitis creates a high burden for both the patients and their loved ones, with persistent itch and recurrent skin lesions often disrupting sleep, school, and social confidence.2-8 Despite the high prevalence and significant burden, treatment options are

Takeda’s ORZEYFUL (oveporexton) Launches Simultaneously in Japan and China Giving Physicians First Access to Prescribe Novel Orexin Agonist to Patients with Narcolepsy Type 115.10.2026 03:30:00 EEST | Press release

Takeda (TSE:4502/NYSE:TAK)announced today that ORZEYFUL (oveporexton) is now available in Japan and China for the treatment of narcolepsy type 1 (NT1), providing first access to clinicians to prescribe treatment with the new class of medicine. ORZEYFUL is a first-in-class orexin receptor 2 (OX2R) agonist, in tablet form, designed to treat the underlying orexin deficiency associated with NT1. “We’re excited at the potential to fundamentally change how NT1 is managed across Japan and China,” said Giles Platford, president, International, Takeda. “We’ve heard from patients how ORZEYFUL has improved their daily functioning and quality of life, enormously meaningful outcomes for a condition known to impact many aspects of a person’s life, including work, education and social interactions.”1,2,3,4,5 NT1 is a chronic, rare neurological disease driven by orexin deficiency. People experience a range of symptoms including excessive daytime sleepiness, cataplexy (sudden loss of muscle tone), disr

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye